Drug Contract Manufacturer Kingchem Life Sciences Targets 1.2 Billion Yuan From Shenzhen IPO-- Kingchem Life Science has priced its initial public offering on the Shenzhen Stock Exchange’s ChiNext board, seeking to raise as much as 1.22 billion yuan. The Chinese contract development and...